Department of Regulatory Affairs, Novartis Pharma AG, 4001 Basel, Switzerland
Short Communication
Decentralized Clinical Trials and Digital Submissions: How Regulatory Affairs is Reinventing Itself in the Post-pandemic Era
Author(s): Makkos Brundin*
DOI:
10.37421/2167-7689.2025.14.476
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 